Deprizine FusePaq

Becocalcidiol The therapeutic efficacy of Becocalcidiol can be decreased when used in combination with Fluocinolone acetonide. Cimetidine The risk or severity of adverse effects can be increased when Cimetidine is combined with Fluocinolone acetonide.

Fluocinolone acetonide - DrugBank

Eplerenone The metabolism of Eplerenone can be increased when combined with Fluocinolone acetonide. Duloxetine The metabolism of Duloxetine can be increased when combined with Fluocinolone acetonide.

Enasidenib The metabolism of Enasidenib can be increased when combined with Fluocinolone acetonide. Studies to determine the carcinogenic and its effect in fertility have not been performed. Epoprostenol Fluocinolone acetonide may decrease the excretion rate of Epoprostenol which could result in a higher serum level.

Fluocinolone acetonide

Formocortal The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Formocortal. Eldecalcitol The therapeutic efficacy of Eldecalcitol can be decreased when used in combination with Fluocinolone acetonide. Azithromycin The metabolism of Azithromycin can be increased when combined with Fluocinolone acetonide.

Children may be more susceptible to systemic toxicity from equivalent doses. Choline salicylate The risk or severity of adverse effects can be increased when Choline salicylate is combined with Fluocinolone acetonide. Gemtuzumab ozogamicin The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Fluocinolone acetonide. Diphenadione The metabolism of Diphenadione can be increased when combined with Fluocinolone acetonide. Gadodiamide Gadodiamide may decrease the excretion rate of Fluocinolone acetonide which could result in a higher serum level.

Dapagliflozin Dapagliflozin may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy. Deferiprone Fluocinolone acetonide may decrease the excretion rate of Deferiprone which could result in a higher serum level. Flurithromycin The metabolism of Fluocinolone acetonide can be decreased when combined with Flurithromycin.

Gallopamil The metabolism of Gallopamil can be increased when combined with Fluocinolone acetonide. Dimercaprol Fluocinolone acetonide may decrease the excretion rate of Dimercaprol which could result in a higher serum level.

Flunitrazepam The metabolism of Flunitrazepam can be increased when combined with Fluocinolone acetonide. Some reports have indicated that fluocinolone acetonide presents a high binding affinity for the glucocorticoid receptor.

Apixaban The metabolism of Apixaban can be increased when combined with Fluocinolone acetonide. Epofolate The metabolism of Fluocinolone acetonide can be decreased when combined with Epofolate.

Deprizine FusePaq - Instruction, Prescriptions, Dosage, Side Effects, Interactions

Asenapine The metabolism of Asenapine can be increased when combined with Fluocinolone acetonide. Ethosuximide The metabolism of Ethosuximide can be increased when combined with Fluocinolone acetonide.

Dactinomycin The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Dactinomycin. Florbetapir 18F Fluocinolone acetonide may decrease the excretion rate of Florbetapir 18F which could result in a higher serum level. Fingolimod The risk or severity of adverse effects can be increased when Fluocinolone acetonide is combined with Fingolimod.